Skip to main content
. 2018 Oct 11;13(10):e0205506. doi: 10.1371/journal.pone.0205506

Table 2. Patients’ characteristics at baseline (November 2007).

Patients with PsA (n = 155) Patients with PsA without CV event (n = 134) Patients with PsA with CV event (n = 21) p value (comparing patients with and without CV event)
Age (years), median (25th–75th Pctl) 48 (40–55) 47 (39–53) 56 (49.5–61) 0.0002
Female, n (%) 95 (61.3) 85 (63.4) 10 (47.6) p = ns
Disease duration (months) at baseline, median (25th–75th Pctl) 50.47 (26.1–99.17) 50.47 (26.1–90.02) 62.63 (38.27–105.2) p = ns
DAS28, median (25th–75th Pctl) 3.75 (2.42–4.705) 3.11 (1.65–4.5) 4.33 (3.89–5) p = 0.01
Axial disease, n (%) 85 (54.83) 73 (54.48) 12 (57.14) p = ns
Peripheral disease, n (%) 133 (85.81) 115 (85.82) 18 (85.71) p = ns
Enthesitis, n (%) 80 (51.61) 68 (50.75) 12 (57.14) p = ns
Dactylitis, n (%) 41 (26.45) 34 (25.37) 7 (33.33) p = ns
PASI, median (25th–75th Pctl) 3.4 (1.575–5.6) 3.2 (1.5–5.6) 3.6 (1.9–8) p = ns
IBD, n (%) 8 (5.16) 7 (5.22) 1 (4.76) p = ns
Uveitis, n (%) 14 (9.03) 9 (6.72) 5 (23.80) p = 0.02
Smokers, n (%) 52 (33.55) 45 (33.58) 7 (33.33) p = ns
Family history CV, n (%) 85 (54.84) 70 (52.24) 15 (71.43) p = ns
Atrial fibrillation, n (%) 6 (3.87) 3 (2.24) 3 (14.29) p = 0.03
Total cholesterol (mg/dl), median (25th–75th Pctl) 187 (164–209) 187.5 (168.3–206) 186 (153–217) p = ns
HDL cholesterol (mg/dl), median (25th–75th Pctl) 52 (43–65) 52 (43–64.25) 55 (42.5–72.5) p = ns
Total cholesterol/HDL cholesterol ratio (n), median (25th–75th Pctl) 3.56 (2.80–4.36) 3.58 (2.81–4.50) 3.16 (2.69–4.19) p = ns
Systolic blood pressure (mmHg), median (25th–75th Pctl) 125 (120–135) 120 (120–130) 145 (130–150) p<0.0001
Antihypertensive treatment, n (%) 50 (32.26) 32 (23.88) 18 (85.71) p<0.0001
BMI, median (25th–75th Pctl) 26.17 (23.67–29.21) 25.93 (23.49–28.73) 27.01 (24.65–30.2) p = ns
CRP (mg/l), median (25th–75th Pctl) 7 (1.6–25) 7 (1.6–25) 5 (0.7–26.5) p = ns
SCORE, median (25th–75th Pctl) 1 (1–3) 1 (0–2) 3 (2–5) p<0.0001
CUORE, median (25th–75th Pctl) 1.8 (0.8–3.6) 1.45 (0.7–2.8) 5.2 (3.4–8.4) p<0.0001
FRS, median (25th–75th Pctl) 2 (0.6–4.9) 1.5 (0.4–3.95) 4.1 (2.9–10) p<0.0001
RRS, median (25th–75th Pctl) 4 (2–6.5) 3 (2–5) 8 (4–15) p<0.0001
QRisk, median (25th–75th Pctl) 4.5 (1.6–9.6) 3.55 (1.375–7.725) 13.4 (10.55–21.75) p<0.0001